CCI
TPST icon

Columbus Circle Investors’s Tempest Therapeutics TPST Stock Holding History

Columbus Circle Investors’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-95
Closed -$8.06M – 309
2015
Q2 		$8.06M Buy
95
+14
+17% +$1.28M 0.06% 219
2015
Q1 		$8.26M Buy
81
+79
+3,950% +$10.5M 0.06% 218
2014
Q4 		$321K Buy
+2
New +$146K ﹤0.01% 284

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OH
Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Columbus Circle Investors's TPST Position: Q3 2015 in Review

Columbus Circle Investors sold out of Tempest Therapeutics (TPST) in Q3 2015, closing a stake of 95 shares — an estimated $8.06M sold.

Columbus Circle Investors first reported a position in TPST in Q4 2014 and held it in 3 quarters. The position peaked at $8.26M in Q1 2015. 90 funds tracked by Wall St. Rank hold TPST as of Q3 2015.

  • Columbus Circle Investors reported no remaining Tempest Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Columbus Circle Investors sold 95 Tempest Therapeutics shares in Q3 2015, an estimated $8.06M.
  • Columbus Circle Investors first reported a position in Tempest Therapeutics in Q4 2014 and held it in 3 quarters.
  • Columbus Circle Investors's Tempest Therapeutics position peaked at $8.26M in Q1 2015.
  • 90 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2015.

Based on Columbus Circle Investors's 13F filing for Q3 2015, filed 2 Nov 2015.